877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Organofluorides, Cyclic compounds

Categories

Halides (27)
Organohalides (27)
Five-membered rings (13)
Pharmaceuticals (10)
Alcohols (6)
Six-membered rings (6)
Tetrahydrofurans (6)
Antineoplastic and immunomodulating drugs (4)
Antineoplastic drugs (4)
Aromatic compounds (4)
Cycloalkanes (4)
Cyclopropanes (4)
Drugs acting on the gastrointestinal system and metabolism (4)
Fluoroarenes (4)
Three-membered rings (4)
Antimetabolites (3)
Antineoplastic antimetabolites (3)
Heterocyclic compounds (3)
Organoiodides (3)
Oxathiolanes (3)
Pyrimidine antagonists (3)
Dihydrofurans (2)
Drugs acting on the nervous system (2)
Drugs for acid-related disorders (2)
Ethers (2)
Heterocyclic compounds (2 rings) (2)
Ketones (2)
Laxatives (2)
Proton pump inhibitors (2)
Pyridines (2)
Pyrimidines (2)
Tetrazoles (2)
Ureas (2)
Acids (1)
Anesthetics (1)
Antiarrhythmic agents (1)
Antiasthmatic drugs (1)
Benzodiazepines (1)
Carboxylic acids (1)
Chalcogenides (1)
Drugs acting on the cardiovascular system (1)
Drugs acting on the respiratory system (1)
Experimental cancer drugs (1)
Fluranes (1)
Gastrointestinal system drug (1)
General anesthetics (1)
Heterocyclic compound (1)
Nervous system drug (1)
Organic acids (1)
Organochlorides (1)
PDE4 inhibitors (1)
Piperazines (1)
Piperidines (1)
Polycyclic organic compounds (1)
Psychoactive drugs (1)
Respiratory agents (1)
Sodium channel blockers (1)
Sulfides (1)
Tetracyclic compounds (1)

Suppliers

Sigma Aldrich (8)
AK Scientific (7)
Matrix Scientific (3)
Toronto Research Chemicals (3)
TCI Chemicals (3)
Apollo Scientific (2)
Amazon (1)
Frontier Scientific (1)
SynQuest Laboratories (1)

Emtricitabine (143491-57-0, 143491-54-7)  
Emtricitabine (commonly called FTC, systematic name 2',3'-dideoxy-5-fluoro-3'-thiacytidine), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse transcriptase inhibitor (NRTI) for the prevention and treatment of HIV infection in adults and children. Emtricitabine is also marketed in a fixed-dose combination with tenofovir (Viread) under the brand name Truvada. A fixed-dose triple combination of emtricitabine, tenofovir and efavirenz (Sustiva, marketed by Bristol-Myers Squibb) was approved by the U.S.
lansoprazole (103577-45-3)  
Prevacid  ·  TAP Brand of Lansoprazole  ·  Lansoprazole Hormona Brand
Lansoprazole, sold under the brand name Prevacid among others, is a medication which inhibits the stomach's production of acid. There is no evidence that its effectiveness is different from that of other PPIs. Lansoprazole, given through a nasogatric tube, effectively controls pH inside the stomach and is an alternative to intravenous pantoprazole in people who are unable to swallow solid-dose formulations.
Lubiprostone (333963-40-9, 136790-76-6)  
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. It was initially approved by the U.S. Food and Drug Administration (FDA) in 2006 and recommended for use in the by the National Institute for Health and Care Excellence (NICE) in 2014.
Voriconazole (137234-62-9)  
Voriconazole, sold under the brand name Vfend among others, is an antifungal medication used to treat a number of fungal infections. This includes aspergillosis, candidiasis, coccidioidomycosis, histoplasmosis, penicilliosis, and infections by Scedosporium or Fusarium. It can be taken by mouth or used by injection into a vein.
Roflumilast (162401-32-3)  
Roflumilast (trade names Daxas, Daliresp) is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD). In June 2010, it was approved in the EU for severe COPD associated with chronic bronchitis.
flecainide (54143-55-4)  
Tambocor  ·  Flecainide Acetate  ·  Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer
Flecainide acetate ( flek-AY-nyde) is a class Ic antiarrhythmic agent used to prevent and treat tachyarrhythmias (abnormal fast rhythms of the heart). It is used to treat a variety of cardiac arrhythmias including paroxysmal atrial fibrillation (episodic irregular heartbeat originating in the upper chamber of the heart), paroxysmal supraventricular tachycardia (episodic rapid but regular heartbeat originating in the atrium), and ventricular tachycardia (rapid rhythms of the lower chambers of the heart). Flecainide works by regulating the flow of sodium in the heart, causing prolongation of the cardiac action potential.
Novaluron (116714-46-6)  
Novaluron, or (±)-1-[3-chloro-4-(1,1,2-trifluoro-2-trifluoro- methoxyethoxy)phenyl]-3-(2,6-difluorobenzoyl)urea, is a chemical with pesticide properties, belonging to the class of insecticides called insect growth regulators. It is a benzoylphenyl urea developed by Makhteshim-Agan Industries Ltd.. In the United States, the compound has been used on food crops, including apples, potatoes, brassicas, ornamentals and cotton.
RU-0211 (136790-76-6)  
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. It was initially approved by the U.S. Food and Drug Administration (FDA) in 2006 and recommended for use in the by the National Institute for Health and Care Excellence (NICE) in 2014.
Lufenuron (103055-07-8)  
Lufenuron is the active ingredient in the veterinary flea control medication Program, and one of the two active ingredients in the flea, heartworm, ringworm and anthelmintic medicine milbemycin oxime/lufenuron (Sentinel). Lufenuron is stored in the animal's body fat and transferred to adult fleas through the host's blood when they feed. Adult fleas transfer it to their growing eggs through their blood, and to hatched larvae feeding on their excrement.
tegafur (82294-77-7, 17902-23-7)  
Ftorafur  ·  FT 207  ·  1-(Tetrahydro-2-furanyl)-5-fluorouracil
Tegafur (INN, BAN, USAN) is a chemotherapeutic prodrug of 5-fluorouracil (5-FU) used in the treatment of cancers. It is a component of the combination drug tegafur/uracil. When metabolised, it becomes 5-FU.
Dithiopyr (97886-45-8)  
Dithiopyr is a preemergent herbicide for crabgrass control in turf and ornamental grasses. It is effective on 45 grassy and broadleaf weeds. Dithiopyr inhibits root growth of susceptible weeds as well as turf grass and thus should be used only on established turf with a well-developed root system.
Sitafloxacin (163253-35-8, 127254-12-0)  
Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.
Flomoxef (99665-00-6)  
Flomoxef (INN) is an oxacephem antibiotic. It has been classified as second-generation and fourth-generation.
Elvucitabine (181785-84-2)  
Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Achillion Pharmaceuticals, Inc. for the treatment of HIV infection. Elvucitabine belongs to a class (group) of HIV drugs called nucleoside reverse transcriptase inhibitors (NRTIs).
Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
Dexelvucitabine (134379-77-4)  
Dexelvucitabine is a failed experimental agent for the management of HIV infection. Dexelvucitabine is a cytidine nucleoside analog and nucleoside reverse transcriptase inhibitor. It was found to inhibit HIV-1 replication in vitro and during Phase II clinical trials, it was found to decrease mean viral load in patients with HIV.
FIALURIDINE (69123-98-4)  
Fialuridine, or 1-(2-deoxy-2-fluoro-1-D-arabinofuranosyl)-5-iodouracil (FIAU), is a nucleoside analogue that was investigated as a potential therapy for hepatitis B virus infection. In a 1993 clinical study at the NIH, unexpected toxicity led to the death of 5 out of 15 patients from liver failure associated with lactic acidosis; two further participants required liver transplantation. This toxicity was unusual in that it was not predicted by animal studies.
Cefazaflur (58665-96-6)  
Cefazaflur (INN) is a first-generation cephalosporin antibiotic.
5FC-(+)-beta (137530-41-7)  
Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
Related searches
Organofluorides
Cyclic compounds
Next Page >